How biotech companies can identify the right CRO partner to accelerate patient recruitment, improve trial quality, reduce operational burden and deliv...
Pharmaceutical organizations are facing a new challenge that goes beyond clinical development, pharmacovigilance and regulatory submissions: controlli...
Bringing a new therapy to market is one of the most significant milestones in a pharmaceutical or biotechnology company's journey. Yet, while organiza...
Biotech and pharma companies face increasing pressure to accelerate timelines, manage costs, cater to regulatory changes and maintain quality across g...
Scientific breakthroughs in oncology, rare diseases, cell and gene therapies, immunology and precision medicine are increasingly being driven by agile...
25 Years in 25 Voices of Peer Leadership For 25 years, the forums and peer networks powered by Navitas Life Sciences have brought together pharmaceuti...
How Foundations, Biotech and Pharma Organizations Can Accelerate Parkinson’s Studies with the Right Clinical Research Partner Parkinson’...
How integrated clinical, regulatory, pharmacovigilance and data science ecosystems are accelerating global development programs Insights ahead of the ...
Selecting the right clinical research organization (CRO) can determine the success or failure of a biotech company’s clinical program. With inc...
The conversation around R programming has fundamentally changed. What was once viewed as a niche statistical language, largely confined to academia, h...
SAHPRA Application ID Update 2025: Impact on eCTD Submission and eCTD Publishing The South African Health Products Regulatory Authority (SAHPRA) relea...
In 2001, a small group of life sciences leaders came together with a simple but unconventional idea, to create a space where industry peers could coll...
Organizations approaching regulatory approval and commercialization face a rapid expansion in pharmacovigilance requirements, moving from development-...
Biotech Innovation Meets Clinical Trial Excellence Biotech innovation is advancing rapidly but translating breakthroughs into approved therapies remai...
Turning Regulatory Complexity into Strategic Advantage Hybrid and decentralized models are becoming the default architecture for modern clinical devel...
Real-world evidence (RWE) is emerging as a cornerstone of modern clinical development and regulatory strategy for patient-centric innovation. How is r...
Navitas has been awarded the EcoVadis Bronze Medal for the second consecutive year, showcasing the organization’s commitment to Environmental, ...
Understanding Commission Implementing Regulation (EU) 2025/1466 and Pharmacovigilance in 2026 and Beyond Commission Implementing Regulation (EU) 2025/...
PHUSE APAC Connect 2026 brought together clinical data leaders, programmers and statisticians from across the region, and Navitas Life Sciences was pr...
What Is Data Management in Clinical Trials? Data management in clinical trials is the structured process of collecting, validating, cleaning, standard...